A-Alpha Bio is a biotechnology company that leverages synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Their experimental platform, Alpha Seq, allows for the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously, while their computational platform, Alpha Bind, predicts binding strength from sequence using the world’s largest protein-protein interaction database. A-Alpha Bio collaborates with leading pharmaceutical companies to inform the discovery and development of novel therapeutics, positioning itself as a key player in therapeutic discovery and optimization.

Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading academic institutions. We're committed to staying at the cutting edge of protein-based therapeutic discovery to enable the highest quality IGGs, multispecifics, CARs, and other modalities to allow our partners to have the most successful therapeutic programs possible.

Adyn is a precision medicine company focused on personalized birth control solutions. Their flagship product, The Birth Control Test, analyzes hormone levels and genetic risks to help users select the most suitable birth control method, minimizing side effects. By leveraging big data and a personalized approach, Adyn aims to transform reproductive health care, making it more inclusive and scientifically driven. Founded by Elizabeth Ruzzo, PhD, the company is positioned to address significant gaps in medical research and healthcare access, particularly for underrepresented groups.

Aera Therapeutics is a biotechnology company focused on harnessing the power of genetic medicines through its proprietary protein nanoparticle (PNP) delivery platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that package and transfer nucleic acid cargo, addressing the limitations of current delivery technologies. Aera aims to expand the reach of genetic medicines across various therapeutic areas, thereby benefiting a broader patient population. The company is led by a distinguished team of industry leaders and scientists, positioning itself as a key player in the genetic medicine landscape.

Aeva is a technology company specializing in advanced sensing and perception systems for autonomous navigation. Their key products, Aeries II and Atlas, utilize innovative FMCW technology to provide 4D LiDAR sensors that detect velocity and range simultaneously, enhancing the decision-making capabilities of autonomous vehicles and robots. Aeva differentiates itself with automotive-grade sensors designed for mass production, aiming to revolutionize the autonomous mobility market. The company has secured significant contracts, including a $1 billion deal with Daimler Truck, positioning it as a leader in the autonomous sensing space.

Aira is a visual interpreting service that connects individuals who are blind or low vision to professional interpreters via an app, providing secure access to visual information anytime and anywhere. The company partners with organizations to offer the app for free to their employees, students, and customers, promoting inclusivity and accessibility. Aira differentiates itself through its trained interpreters and real-time assistance, making it a vital tool for navigation, participation in daily activities, and engagement in various environments. With a growing network of access partners, Aira is positioned as a leader in the accessibility space, meeting important ADA requirements and fostering a commitment to diversity, equity, and inclusion.

Alife is a company that develops AI-powered software designed to optimize IVF clinic operations, improve patient outcomes, and enhance efficiency. Their key products include Alife Assist™, Stim Assist, and Embryo Assist, which provide actionable insights through data integration and real-time monitoring of clinic KPIs. Alife differentiates itself by leveraging cutting-edge artificial intelligence to support fertility specialists in making informed decisions, ultimately aiming to increase the chances of successful pregnancies. The company has gained traction in the IVF market, with endorsements from various fertility experts and clinics that have reported improved lab efficiency and patient care.

Amca is rapidly developing and acquiring a foundation of critical products that will power the next fifty years of aerospace and defense. We’re fighting for a future where development cycles for new parts, products, and programs are not only possible, but the renewed norm. We welcome you to join us.

Anagenex is a biotechnology company that leverages AI-driven drug discovery to accelerate the development of new medicines. By testing billions of custom-synthesized compounds and utilizing proprietary neural networks, Anagenex iteratively refines its AI predictions to design and test new compounds at an unprecedented scale. With over 100 billion data points and the ability to conduct experiments on hundreds of millions of compounds in just one month, Anagenex aims to significantly reduce the time it takes to bring new drugs to market, addressing the urgent need for faster solutions in the pharmaceutical industry.

Anchorage Digital is a crypto platform that enables institutions to participate in digital assets through custody, staking, trading, governance, settlement, and the industry’s leading security infrastructure. Home to Anchorage Digital Bank N.A., the only federally chartered crypto bank in the U.S., Anchorage Digital also serves institutions through Anchorage Digital Singapore, which is licensed by the Monetary Authority of Singapore; Anchorage Digital New York, which holds a BitLicense from the New York Department of Financial Services; and self-custody wallet Porto by Anchorage Digital. The company is funded by leading institutions including Andreessen Horowitz, GIC, Goldman Sachs, KKR, and Visa, with its Series D valuation over $3 billion. Founded in 2017 in San Francisco, California, Anchorage Digital has offices in New York, New York; Porto, Portugal; Singapore; and Sioux Falls, South Dakota.

Anduril Industries is a defense technology company that specializes in advanced military capabilities, offering a range of products including autonomous systems, air systems, underwater vehicles, and rocket motors. Their Lattice platform integrates these technologies to provide persistent awareness and security across land, sea, and air, positioning them as a leader in the defense sector. With a focus on innovation and solving complex national security challenges, Anduril aims to support military agencies and enhance border surveillance, making them a key player in modern defense solutions.

Applied Intuition is a vehicle software supplier that accelerates the adoption of safe and intelligent machines worldwide. Founded in 2017, Applied Intuition provides a simulation and validation platform for various industries such as automotive, trucking, construction, and more. 18 of the top 20 global automakers rely on Applied Intuition’s solutions to shorten development cycles, deliver high-quality systems, and accelerate the production of modern vehicles with confidence. Applied Intuition is headquartered in Mountain View, CA, with offices in Ann Arbor, MI, Detroit, Washington, D.C., Munich, Stockholm, Seoul, and Tokyo. Learn more at https://applied.co.